G

Great Point Partners

40 employees

The principals of Great Point Partners have a long history of helping executives build successful health care companies.

Investor insights

Countries invested in

united states1

Sectors invested in

Health Care21
Biotechnology17
Medical10
Therapeutics7
Medical Device5
Biopharma4
Manufacturing4
Information Technology3
CYCLIST2
Lung Transplant2
CIS2
Inhaled Cyclosporine2
Chronic Rejection2
Life Science2
Pharmaceutical2
Hospital2
Analytics2
Software2
Health Insurance Marketplaces1
Dietary Supplements1

Funding rounds participated in

$27M sweet spot round size

Most of their 34 investments are in rounds between $17M and $52M

Investor type

Private Equity Firm

Basic info

Industry

financial services

Sectors

Financial Services
Health Care
Finance

Date founded

2003

Investments made

Z

Zura Bio Limited raised $80M on April 27, 2023

Investors: Suvretta Capital Management LLC and Great Point Partners

I

Immunic Therapeutics raised $60M on October 10, 2022

Investors: Logos Global Management, LP, RTW Investments, LP, The Invus Group, Commodore Capital, LP, Parkman Healthcare Partners LLC, Vivo Capital and Great Point Partners

i

iXCells Biotechnologies raised undisclosed on September 29, 2022

Investors: Great Point Partners

V

Ventyx Biosciences raised $177M on September 19, 2022

Investors: Walleye Capital, Logos Global Management, LP, CaaS Capital Management, Woodline Partners LP, Vivo Capital, Redmile Group, Driehaus Capital Management LLC and Great Point Partners

H

Heron Therapeutics, Inc. raised $77M on August 9, 2022

Investors: Great Point Partners

U

Undisclosed raised undisclosed on July 22, 2022

Investors: Great Point Partners

J

JPA Health Communications raised undisclosed on May 4, 2022

Investors: Great Point Partners

V

Velentium raised undisclosed on September 30, 2021

Investors: Great Point Partners

B

BioAtla, Inc. raised $75M on September 29, 2021

Investors: Ikarian Capital LLC, Monashee Investment Management LLC, Hudson Bay Capital Management LP, Soleus Capital Management, L.P., Pappas Capital and Great Point Partners

M

Magenta Therapeutics raised $86M on May 12, 2021

Investors: TCG X and Great Point Partners

FAQ